Since the peptide works via the release of Growth Hormone and IGF-1, you can already expect a long list of effects
Scientific interest in GHK-Cu continues to grow thanks to its ability to restore cellular mechanisms that gradually decline with age or due to excessive damage
Cagrilintide and retatrutide are two investigational medicines being developed primarily for the treatment of obesity and type 2 diabetes
It works closely with enzymes like superoxide dismutase, which helps break down potentially harmful oxygen molecules in cells
Individuals with high intakes of dietary fiber appear to be at significantly lower risk for developing obesity, along with coronary heart disease, stroke, hypertension, diabetes, and certain gastrointestinal diseases
Other musculoskeletal research has looked at ligament healing, tendon fibroblast activity, angiogenesis, and muscle injury models